Pictet Asset Management’s AstraZeneca AZN Stock Holding History

Pictet Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$550M	Sell	2,937,510 -544,354	-16%	-$102M	0.53%	34
2026 Q1	$675M	Buy	+3,481,864	New	+$671M	0.71%	24
2025 Q1	–	Sell	-284,650	Closed	-$37.3M	–	2018
2024 Q4	$37.3M	Sell	284,650 -26,952	-9%	-$3.77M	0.04%	355
2024 Q3	$48.4M	Sell	311,602 -55,265	-15%	-$8.92M	0.05%	298
2024 Q2	$57.2M	Sell	366,867 -385,327	-51%	-$58M	0.07%	258
2024 Q1	$102M	Sell	752,194 -124,794	-14%	-$16.5M	0.11%	205
2023 Q4	$118M	Buy	876,988 +35,301	+4%	+$4.59M	0.13%	183
2023 Q3	$114M	Buy	+841,687	New	+$115M	0.14%	179

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pictet Asset Management's AZN Position: Q2 2026 in Review

Pictet Asset Management reduced its AstraZeneca (AZN) stake by 16% in Q2 2026, selling an estimated $102M and leaving 2,937,510 shares worth $550M. The position accounts for 0.53% of the portfolio, ranked #34.

Pictet Asset Management first reported a position in AZN in Q3 2023 and has held it in 8 quarters since. The position peaked at $675M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Pictet Asset Management held 2,937,510 shares of AstraZeneca worth $550M as of Q2 2026.
Pictet Asset Management sold 544,354 AstraZeneca shares in Q2 2026, an estimated $102M.
AstraZeneca made up 0.53% of Pictet Asset Management's portfolio in Q2 2026, its #34 holding.
Pictet Asset Management first reported a position in AstraZeneca in Q3 2023 and has held it in 8 quarters since.
Pictet Asset Management's AstraZeneca position peaked at $675M in Q1 2026.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.